Hydrocephalus in mucopolysaccharidosis Type VI successfully treated with endoscopic third ventriculostomy

Case report

Restricted access

Mucopolysaccharidosis (MPS) Type VI, or Maroteaux-Lamy syndrome, is characterized by a deficiency of the enzyme arylsulfatase B (ASB). In patients with this disorder, craniocervical compression, carpal tunnel syndrome, and communicating hydrocephalus are common. Traditionally, hydrocephalus occurring in patients with MPS VI has been treated with shunt placements. Considering obstruction of the outlets from the fourth ventricle at the craniocervical transition, the authors decided to treat a female patient with MPS VI via endoscopic third ventriculostomy. She was 12 years old and had refractory headaches. This seems to be the first reported instance of the neuroendoscopic treatment of hydrocephalus in a patient with MPS VI. The pathophysiology is briefly discussed.

Abbreviations used in this paper:ASB = arylsulfatase B; GAG = glycosaminoglycan; MPS VI = mucopolysaccharidosis Type VI.

Article Information

Address correspondence to: Ângelo Raimundo da Silva Neto, M.D., M.Sc., Department of Neurosurgery, Avenue Deodoro da Fonseca 498, 59065-600 Natal, Rio Grande do Norte, Brazil. email: angelorsn@gmail.com.

Please include this information when citing this paper: published online January 11, 2013; DOI: 10.3171/2012.11.PEDS11419.

© AANS, except where prohibited by US copyright law.

Headings

Figures

  • View in gallery

    Sagittal T2-weighted MR image showing obstruction of the outlets from the fourth ventricle and hydrocephalus in association with cord compression at the craniocervical transition.

  • View in gallery

    Endoscopic view from the floor of the third ventricle showing a thick membrane in front of mammillary bodies.

  • View in gallery

    Sagittal T2-weighted MR image obtained 6 months after surgery, showing radiological improvement in craniocervical transition with no blockage in the fourth ventricle.

References

1

Aliabadi HReynolds RPowers CJGrant GFuchs HKurtzberg J: Clinical outcome of cerebrospinal fluid shunting for communicating hydrocephalus in mucopolysaccharidoses I, II, and III: a retrospective analysis of 13 patients. Neurosurgery 67:147614822010

2

Choux MGenitori LLang DLena G: Shunt implantation: reducing the incidence of shunt infection. J Neurosurg 77:8758801992

3

Cinalli GSpennato PRuggiero CAliberti FTrischitta VBuonocore MC: Complications following endoscopic intracranial procedures in children. Childs Nerv Syst 23:6336442007

4

Erşahin YArslan D: Complications of endoscopic third ventriculostomy. Childs Nerv Syst 24:9439482008

5

Giugliani RHarmatz PWraith JE: Management guidelines for mucopolysaccharidosis VI. Pediatrics 120:4054182007

6

Jenkinson MDHayhurst CAl-Jumaily MKandasamy JClark SMallucci CL: The role of endoscopic third ventriculostomy in adult patients with hydrocephalus. Clinical article. J Neurosurg 110:8618662009

7

Kadrian Dvan Gelder JFlorida DJones RVonau MTeo C: Long-term reliability of endoscopic third ventriculostomy. Neurosurgery 62:Suppl 26146212008

8

Kandasamy JKneen RGladstone MNewman WMohamed TMallucci C: Chiari I malformation without hydrocephalus: acute intracranial hypertension managed with endoscopic third ventriculostomy (ETV). Childs Nerv Syst 24:149314972008

9

Kawaguchi TFujimura MTominaga T: Syringomyelia with obstructive hydrocephalus at the foramens of Luschka and Magendie successfully treated by endoscopic third ventriculostomy. Surg Neurol 71:3493522009

10

Koseoglu STHarmatz PTurbeville SNicely H: Reversed papilledema in an MPS VI patient with galsulfase (Naglazyme) therapy. Int Ophthalmol 29:2672692009

11

Massimi LPravatà ETamburrini GGaudino SPettorini BNovegno F: Endoscopic third ventriculostomy for the management of Chiari I and related hydrocephalus: outcome and pathogenetic implications. Neurosurgery 68:9509562011

12

Maroteaux PLeveque BMarie JLamy M: [A new dysostosis with urinary elimination of chondroitin sulfate B.]. Presse Med 71:184918521963. (Fr)

13

Schwartz GPCohen EJ: Hydrocephalus in Maroteaux-Lamy syndrome. Arch Ophthalmol 116:4001998. (Letter)

14

Valayannopoulos VNicely HHarmatz PTurbeville S: Mucopolysaccharidosis VI. Orphanet J Rare Dis 5:52010

15

Vedolin LSchwartz IVKomlos MSchuch APuga ACPinto LLC: Correlation of MR imaging and MR spectroscopy findings with cognitive impairment in mucopolysaccharidosis II. AJNR Am J Neuroradiol 28:102910332007

16

Vougioukas VIBerlis AKopp MVKorinthenberg RSpreer Jvan Velthoven V: Neurosurgical interventions in children with Maroteaux-Lamy syndrome. Case report and review of the literature. Pediatr Neurosurg 35:35382001

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 2 2 2
Full Text Views 15 15 11
PDF Downloads 82 82 51
EPUB Downloads 0 0 0

PubMed

Google Scholar